Comparison of Ba-Duan-Jin and Pregabalin in Patients With Fibromyalgia
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
Fibromyalgia is a chronic debilitating musculoskeletal pain syndrome. Pregabalin is the only
medication that has been approved to treat fibromyalgia in China. Currently, there has been a
growing interest in the development of non-pharmacological therapies. Ba-Duan-Jin is an
ancient Chinese exercise for health promotion yet easy to learn. Findings from our previous
study showed an effectiveness and good safety of Ba-Duan-Jin in patients with fibromyalgia.
This study is to evaluate the effectiveness comparison of Ba-Duan-Jin and pregabalin in
managing fibromyalgia symptoms experienced by Chinese patients.
Phase:
N/A
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences